Skip to content

IBB

iShares Biotechnology ETF

$205.39−1.58 (−0.76%)Close Nov 18, 2026

IBB holdings

252 in all, as of Jun 30, 2026
Holding%Weight (%)Value
BlackRock Funds III11.7$1.06B
VRTXVertex Pharmaceuticals, Inc.8.1$734M
AMGNAmgen, Inc.7.8$711M
GILDGilead Sciences, Inc.6.8$622M
REGNRegeneron Pharmaceuticals, Inc.4.9$446M
ARGXArgenx SE3.8$342M
ALNYAlnylam Pharmaceuticals, Inc.3.1$284M
NTRANatera, Inc.2.9$263M
RVMDRevolution Medicines, Inc.2.8$253M
BIIBBiogen, Inc.2.5$224M

Asset classes

Stocks
99.9%
Cash and equivalents
12.0%
Net other assets
−11.9%

Stock sectors

Health Care
99.5%
Not classified
0.4%

Countries

United States
84.3%
Netherlands
4.3%
Denmark
2.4%
Switzerland
2.2%
Bermuda
1.4%
Canada
1.2%
Cayman Islands
0.9%
Ireland
0.8%